The Second Hospital of Hebei Medical University, Shijiazhuang, China.
Hebei Normal University Sports Rehabilitation Department, Shijiazhuang, China.
Cartilage. 2021 Dec;13(1_suppl):1734S-1740S. doi: 10.1177/1947603520903443. Epub 2020 Feb 10.
We aimed to compare the outcomes of exercise rehabilitation and conventional treatment in patients with knee osteoarthritis.
This trial included a total of 166 patients diagnosed with knee osteoarthritis; they were randomly divided into groups. The experimental group underwent systematic exercise rehabilitation, while the control group received naproxen ( = 28), diclofenac ( = 27), or celecoxib ( = 19). Improvement in symptoms, knee function, and quality of life were compared. SPSS Statistics 24.0 was used for the data analysis.
The mean age of patients was 56.0 ± 10.5 years, and the average follow-up time was 12 ± 2.3 weeks. No statistically significant differences were seen in age, body mass index, and sex ( > 0.05) between the groups. The average Western Ontario and MacMaster Universities (WOMAC) scores after treatment were 84.4 ± 15.2, 108.3 ± 3.9, 107.4 ± 5.4, and 107 ± 6.0 in the exercise rehabilitation, diclofenac, naproxen, and celecoxib groups, respectively. The mean Lysholm scores were 60.3 ± 14.9, 41.0 ± 0.1, 43.5 ± 5.3, and 41.7 ± 3.6 in the exercise rehabilitation, diclofenac, naproxen, and celecoxib groups, respectively. The mean SF-36 (Short Form-36 Survey) scores were 105.4 ± 21.5, 82.5 ± 3.7, 84.2 ± 3.5, and 83.7 ± 5.0 in the exercise rehabilitation, naproxen, celecoxib, and diclofenac groups, respectively. The average ranges of knee motion were 125.0 ± 6.2°, 116.4 ± 1.4°, 114.7 ± 1.1°, and 115.7 ± 0.8° after exercise rehabilitation, diclofenac, naproxen, and celecoxib treatments, respectively. These data presented statistical differences between the groups.
Exercise better improved symptoms and quality of life in patients with knee osteoarthritis over a 12-week follow-up period than that achieved with nonsteroidal anti-inflammatory drugs and COX-2 inhibitors.
比较膝关节骨关节炎患者进行运动康复和常规治疗的效果。
本试验共纳入 166 例膝关节骨关节炎患者,随机分为两组。实验组进行系统的运动康复,对照组分别给予萘普生(=28)、双氯芬酸(=27)或塞来昔布(=19)治疗。比较症状、膝关节功能和生活质量的改善情况。数据分析采用 SPSS Statistics 24.0 统计软件。
患者平均年龄为 56.0±10.5 岁,平均随访时间为 12±2.3 周。治疗后,各组的平均 Western Ontario and MacMaster Universities(WOMAC)评分分别为运动康复组 84.4±15.2、双氯芬酸组 108.3±3.9、萘普生组 107.4±5.4、塞来昔布组 107±6.0;Lysholm 评分分别为运动康复组 60.3±14.9、双氯芬酸组 41.0±0.1、萘普生组 43.5±5.3、塞来昔布组 41.7±3.6;SF-36(健康调查简表)评分分别为运动康复组 105.4±21.5、萘普生组 82.5±3.7、塞来昔布组 84.2±3.5、双氯芬酸组 83.7±5.0;膝关节运动范围分别为运动康复组 125.0±6.2°、双氯芬酸组 116.4±1.4°、萘普生组 114.7±1.1°、塞来昔布组 115.7±0.8°。这些数据在组间存在统计学差异。
与非甾体抗炎药和 COX-2 抑制剂相比,运动康复在 12 周的随访期间更能改善膝关节骨关节炎患者的症状和生活质量。